We so appreciate the significant contributions of Li Lan, PhD, and Clemens Grassberger, PhD, as Associate Directors of the Program. As both Li and Clemens move on to new career challenges at other institutions, they leave the Program in great shape!
We are fortunate to have had a number of truly outstanding, and diverse, speakers in the last couple of years. Stay tuned for more to come!
April 2021
Julie K Schwarz, MD PhD, WashU
Using Imaging and Genomics to define Biomarkers of Radiation Sensitivity in Gynecologic Cancers
September 2021
Meredith A Morgan, PhD, UMich
Enhancing radiation-induced immunity with inhibitors of the DNA damage response in pancreatic cancer
January 2022
Timothy A Chan, MD PhD, Cleveland Clinic
How Immune Cells Recognize Tumor Cells and Why It Matters in Radiation Oncology
April 2022
Anthony Chalmers, MD PhD, U Glasgow
Combining radiation therapy with inhibitors of the DNA damage response in glioblastoma and other cancers: a ‘bench-to-bedside’ odyssey’
September 2022
Ralph Weichselbaum, MD PhD, U Chicago
Oligometastatic Cancer: Illusion or Reality
January 2023
David S Yu, MD PhD, Emory
Understanding and Exploiting the DNA Damage Response for Cancer Therapy
April 2023
Freddy E Escorcia, MD, PhD, NCI
Radiation Oncology meets Radiopharmaceuticals for Hepatocellular Carcinoma *In Person*
On April 27, 2021, We were thrilled to host our first radiation/cancer biology Grand Rounds speaker, Dr. Julie Schwarz, Professor of Radiation Oncology, Vice Chair of Research, and Director of the Cancer Biology Division at Washington University. She gave an inspiring lecture on using functional imaging and cancer genomics for predicting radiation sensitivity of cervical cancers.
Today we launched a new series -inspired by Science Mondays in the Cancer Center- to focus on radiation science related topics. Great interest on our first Zoom meeting in reviving collaborations in the radiation/immuno-oncology space. Together, we can lift each other up!
We are extremely pleased to share the Program announcement by our Interim Chief Anthony Zietman, MD below.
You can find the Twitter announcement here.
We would like to thank everybody for their well wishes and support.
We (Li, Clemens & Henning) are very excited to be working toward the Program launch by end of February. Please come back soon to check things out!